CD34+ Stem Cell Selection for Patients Receiving a Matched or Partially Matched Family or Unrelated Adult Donor Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Study of Patients Receiving an Allogeneic Stem Cell Transplantation for Non-Malignant Disease
Sponsor: Investigator initiated study
Enrolling: Male and Female Patients
IRB Number: AAAL0156
U.S. Govt. ID: NCT01966367
Contact: Brian Volonte: (212) 304-7806 / bv2272@cumc.columbia.edu
Additional Study Information: The purpose of this study is to determine the incidence and severity of acute GVHD following CD34+ selection in children, adolescents and young adults receiving an allogeneic peripheral blood stem cell transplant from a family member or unrelated adult donor for a non-malignant condition.
This study is closed
Investigator
Diane George, MD
Do You Qualify?
Is the patient 40 years of age or younger? Yes No
Is the patient a candidate for stem cell transplant for a non-malignant disease? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Brian Volonte
bv2272@cumc.columbia.edu
(212) 304-7806
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE